Indication
Natural Killer Cell Malignancies
2 clinical trials
4 products
4 drugs
Clinical trial
Myeloablative Allogeneic Hematopoietic Cell Transplantation Using a Related or Unrelated Donor for the Treatment of Hematological DiseasesStatus: Recruiting, Estimated PCD: 2025-01-10
Product
HSCT with TBI RegimenProduct
HSCTClinical trial
Transplantation of Umbilical Cord Blood From Unrelated Donors in Patients With Hematological Diseases Using a Non-Myeloablative Preparative RegimenStatus: Active (not recruiting), Estimated PCD: 2023-02-22
Drug
fludarabineDrug
cyclophosphamideDrug
rapamycinProduct
ATG